Active Stem Cell Therapy
A cell-based intervention requiring an individual discussion with a physician. Restoration of neural networks or the same benefit for every child with ASD or cerebral palsy cannot be promised.
How the procedure works
Hanshi NeuroLife in Shangrao lists cell therapy among its medical services and works with Han’s United. Offering a service does not establish that every cell product is effective for ASD or cerebral palsy. Results depend on the studied product, administration route and patient group; targeted conversion of administered cells into neurons and restoration of neural networks cannot be promised.
What research shows
Sun and colleagues, 2020 studied intravenous cord-tissue cells in ASD in an open-label phase I study involving 12 children. This design does not establish guaranteed efficacy for all children or other protocols.
The randomised trial by Gu and colleagues, 2020 reported positive functional-scale results in cerebral palsy for a particular cell protocol combined with rehabilitation. This is a finding from a specific study, not validation of every cell-therapy offering.
Before a decision
The physician should explain the proposed product, the rationale for its use, known risks, alternatives and follow-up. ISSCR patient resources distinguish investigational interventions from established treatments. Citing a study here does not mean the centre’s programme is part of that study.
The intervention and subsequent assessment require an individual discussion. There is no established timetable for speech, motor skills or another outcome. The ASD programme and cerebral palsy rehabilitation pages describe support beyond an individual procedure.
In-depth assessment and review of indications
The specialist physician performs an in-depth assessment: clinical examination, history-taking, neurological and laboratory findings. Indications and contraindications for cell therapy are evaluated.
Selection of an individualized protocol
A cell therapy protocol is selected for the child (dose, frequency, route of administration), taking into account age, disease form, and comorbidities; coordinated with the treating physician.
Procedure performed in an inpatient setting
The procedure is performed in an inpatient setting under the supervision of the medical team of the partner network Han's United (汉氏联合). Cellular material is prepared and administered under controlled conditions.
Tolerability and progress monitoring
Regular monitoring: tolerability of the procedure, neurological progress, changes in priority manifestations, and laboratory monitoring. When indicated — repeat Gesell, PEP, and GMFM assessments.
Final evaluation and decision on continuation
Follow-up timing is agreed with the physician. Tolerability, changes in skills and the next steps are discussed; a positive effect is not assumed in advance.
Indications and contraindications
Indications
Contraindications
What diagnoses it helps with Active Stem Cell Therapy
Book a free consultation
Leave a short request — a coordinator will contact you within 5 minutes, answer your questions and suggest the first steps.